Aytu BioPharma (NASDAQ:AYTU) is preparing to release its quarterly earnings on Tuesday, 2025-09-23. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Aytu BioPharma to report an earnings per share (EPS) of $-0.04.
The market awaits Aytu BioPharma’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Earnings Track Record
During the last quarter, the company reported an EPS beat by $0.38, leading to a 91.85% increase in the share price on the subsequent day.
Here’s a look at Aytu BioPharma’s past performance and the resulting price change:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | 0 | -0.34 | -0.45 |
| EPS Actual | 0.21 | -0.28 | -0.20 | -0.82 |
| Price Change % | 92.00% | -1.00% | -11.00% | -17.00% |
Performance of Aytu BioPharma Shares
Shares of Aytu BioPharma were trading at $2.44 as of September 19. Over the last 52-week period, shares are up 1.44%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Insights Shared by Analysts on Aytu BioPharma
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Aytu BioPharma.
Aytu BioPharma has received a total of 2 ratings from analysts, with the consensus rating as Buy. With an average one-year …